99mTc-labelled human serum albumin cannot replace 125I-labelled human serum albumin to determine plasma volume in patients with liver disease

被引:7
|
作者
Henriksen, Ulrik Luetken [1 ]
Henriksen, Jens H. [1 ]
Bendtsen, Flemming [2 ]
Moller, Soren [1 ]
机构
[1] Univ Copenhagen, Hvidovre Hosp, Ctr Funct & Diagnost Imaging & Res, DK-2650 Copenhagen, Denmark
[2] Univ Copenhagen, Fac Hlth Sci, Dept Gastroenterol 439, Hvidovre Hosp, DK-2650 Copenhagen, Denmark
关键词
cirrhosis; indicator heterogeneity; intravascular indicators; plasma volume determination; volume of distribution; ARTERIAL COMPLIANCE; CIRRHOSIS; PROTEIN; COMPLICATIONS; EXPANSION; FLUID;
D O I
10.1111/cpf.12015
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background and aims Determination of plasma volume (PV) is important in several clinical situations. Thus, patients with liver disease often have augmented PV as part of their sodiumwater retention. This study was undertaken to compare PV determination by two indicators: technetium-labelled human serum albumin (99mTc-HSA) and iodine-labelled human serum albumin (125I-HSA), as the former may have advantages at repeated measurements and the latter is the classical gold standard. Study population and methods In 88 patients, (64 with liver disease, mainly cirrhosis, and 24 patients without liver disease), simultaneous measurements of PV were taken with 99mTc-HSA and 125I-HSA after 1h in the supine position. Blood samples were obtained before and 10min after quantitative injection of the two indicators. In a subset of patients (n=32), the measurements were repeated within 1h. Results In all patients, a close correlation was present between PV determined by the two indicators (r=0 center dot 89, P<0 center dot 0001). In all, but twelve patients, a higher PV was obtained with 99mTc-HSA compared with 125I-HSA (P<0 center dot 0001). PV determined with 99mTc-HSA exceeded PV determined with 125I-HSA by 367ml (5 center dot 2mlkg1) in liver patients as compared to 260ml (3 center dot 5mlkg1) in patients without liver disease (P<0 center dot 05). The precision of repeated PV determination was 1 center dot 75% (coefficient of variation) with 99mTc-HSA and 1 center dot 71% with 125I-HSA (ns), and similar values were found in patients with and without liver disease. Conclusion The study demonstrates that 99mTc-HSA has the same precision as that of 125I-HSA. However, especially in patients with liver disease, 99mTc-HSA consistently overestimates the PV, most likely owing to indicator heterogeneity with subsequent fast removal from the circulating medium with a higher volume of distribution as the outcome.
引用
收藏
页码:211 / 217
页数:7
相关论文
共 50 条